Articles Tagged With: COVID-19
-
OCR Releases Guidance on Audio-Only Telehealth
The Office for Civil Rights (OCR) recently issued guidance on how covered entities can use audio-only telehealth services in compliance with HIPAA. In line with what is referred to as the common carrier exception, OCR clarified the Security Rule does not apply to audio-only telehealth services provided by a covered entity that is using a standard landline.
-
Outcomes of COVID-19-Associated Acute Myocarditis
In a review of COVID-19-associated acute myocarditis, investigators learned it is a rare complication that can occur without concomitant pneumonia, and frequently presents as cardiogenic shock. With supportive therapy, the short-term mortality rate is low.
-
COVID-19 Infection Course Worse in Patients Receiving Anti-CD20 Treatment
In this retrospective cohort, patients receiving anti-CD20 treatment had worse clinical outcomes, including mortality, in addition to longer durations of infectivity and higher rates of relapse.
-
Feds Order Bivalent Vaccines with Omicron
The Biden administration is securing orders for bivalent vaccines that are expected to combine the original Wuhan strain with omicron subvariants BA.4 and BA.5.
-
IP ‘Ambassadors’ Extend Program’s Pandemic Reach
Some infection preventionists have extended their reach by recruiting infection control champions or ambassadors to keep their colleagues updated on the ongoing changes and recommendations in the pandemic response.
-
Vaccinate Children Against MIS-C, a Serious Post-COVID Syndrome
COVID-19 vaccination can greatly reduce multisystem inflammatory syndrome in children, a rare but serious complication associated with SARS-CoV-2 infection, researchers are finding.
-
Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373)
Novavax is authorized to be administered to patients age 18 years and older for active immunization to prevent COVID-19 caused by SARS-CoV-2.
-
COVID-19 Rebound
Symptomatic and virologic recrudescence after treatment of patients with COVID-19 with Paxlovid occurs in a tiny percentage of patients and generally is mild and self-limited.
-
COVID-19: Duration of Shedding of Transmissible Virus
Patients with COVID-19 were found, by culture, to shed replication-competent virus after an initial PCR test for median durations of four to five days.
-
Healthcare Workers Likely Will Be Offered New Vaccine
Healthcare workers likely will be offered a new COVID-19 vaccine the FDA is pushing to roll out for this fall and winter. The FDA Vaccines and Related Biological Products Advisory Committee approved “the inclusion of a SARS-CoV-2 omicron component for COVID-19 booster vaccines in the United States.”